11.25% p.a. Early Redemption Kick-In GOAL

Underlying: Idorsia Ltd / Novartis / Roche / Vifor Pharma AG SSPA/EUSIPA Product Type: Barrier Reverse Convertibles (1230, Auto-Callable) SIX symbol: KELIDU / Valor: 50426278 / ISIN: CH0504262780

Last update 07.08.2020
  • Bid

    87.50 %
    Volume: 100'000

  • Ask

    88.50 %
    Volume: 100'000